Salk Institute

Diabetes

First immune-evading cells created to treat type 1 diabetes

Salk Institute scientists have made a major advance in the pursuit of a safe and effective treatment for type 1 diabetes, an illness that impacts an estimated 1.6 million Americans with a cost of $14.4 billion annually.

Alzheimer's disease & dementia

New molecule reverses Alzheimer's-like memory decline

A drug candidate developed by Salk researchers, and previously shown to slow aging in brain cells, successfully reversed memory loss in a mouse model of inherited Alzheimer's disease. The new research, published online in ...

Oncology & Cancer

Mysterious tuft cells found to play role in pancreatitis

Persistent inflammation of the pancreas (chronic pancreatitis) is a known risk factor for developing pancreatic cancer, the third-deadliest cancer in the United States. Tuft cells—cells sensitive to chemical (chemosensory) ...

Genetics

Scientists link rapid brain growth in autism to DNA damage

Researchers at the Salk Institute have discovered a unique pattern of DNA damage that arises in brain cells derived from individuals with a macrocephalic form of autism spectrum disorder (ASD). The observation, published ...

page 9 from 40